Press release
MSF: TB test price reduction by Cepheid and Danaher is an important step in the...
September 19, 2023 |
Access campaign
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to...
September 12, 2023 |
Access campaign
TB medicine deal offers short-term solution, but J&J needs to do more for all affected...
July 14, 2023 |
Press release
MSF demands J&J give up its patent monopoly on TB drug to put lives over...
April 27, 2023 |
Access campaign
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
March 31, 2023 | Switzerland
Access campaignPress release
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on...
March 23, 2023 |
Press release
Urgent need to improve access to TB testing to support rollout of better, safer, shorter...
March 22, 2023 | India
Press release
Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis
December 21, 2022 | United Kingdom
Access campaign
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
November 30, 2022 | Switzerland
Access campaignPress release
United Kingdom
MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement
November 2, 2022 | IndiaUnited Kingdom
Access campaignPress release
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments...
October 28, 2022 |
Access campaign
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the...
June 17, 2022 | Switzerland
